INFLUENCE OF GENDER ON IN-HOSPITAL CLINICAL AND ANGIOGRAPHIC OUTCOMESAND ON ONE-YEAR FOLLOW-UP IN THE NEW-APPROACHES-TO-CORONARY-INTERVENTION (NACI) REGISTRY
T. Robertson et al., INFLUENCE OF GENDER ON IN-HOSPITAL CLINICAL AND ANGIOGRAPHIC OUTCOMESAND ON ONE-YEAR FOLLOW-UP IN THE NEW-APPROACHES-TO-CORONARY-INTERVENTION (NACI) REGISTRY, The American journal of cardiology, 80(10A), 1997, pp. 26-39
Higher complication rates and lower success rates for treatment of wom
en compared with men have been reported in prior studies of coronary a
ngioplasty and in most early reports of outcome with new coronary inte
rventional devices. In multivariate analysis this has been attributed
largely to older age and other unfavorable clinical characteristics. T
hese results are reflected in the current guidelines for coronary angi
oplasty. Women in prior studies have also had different distributions
of vessel and lesion characteristics, but the influence of these diffe
rences on the outcome of new-device interventions have not been adequa
tely evaluated. This article evaluates the influence of gender on clin
ical and angiographic characteristics, interventional procedure and co
mplications, angiographic success, and clinical outcomes at hospital d
ischarge and 1-year follow-vp, as observed in the New Approaches to Co
ronary Intervention (NACI) registry. The NACI registry methodology has
been reported in detail elsewhere in this supplement. This study focu
ses on the 90% of patients-975 women and 1,880 men-who had planned pro
cedures with a single new device and also had angiographic core labora
tory readings. Women compared with men were older, had more recent ons
et of coronary ischemic pain that was more severe and unstable, and ha
d more frequent histories of other adverse clinical conditions. The di
stributions of several but not all angiographic characteristics before
intervention were considered more favorable to angioplasty outcome in
women. Differences were observed in device use and procedure staging.
Angiographically determined average gain in lumen diameter after new-
device intervention, with or without balloon angioplasty, was signific
antly less in women (1.38 mm) than in men (1.53 mm; p < 0.001); this 0
.15 mm difference is consistent with the 0.16-mm smaller reference ves
sel lumen diameter of women. However, final percent diameter stenoses
and TIMI flow and lesion compliance characteristics were similar. Amon
g procedural complications, only treatment for hypotension, blood tran
sfusion, and vascular repair occurred more often in women. More women
than men were clinically unstable (2.1% vs 1.1%) or went directly to e
mergent coronary artery bypass graft surgery (CABG; 1.2% vs 0.6%) on l
eaving the interventional laboratory. However, in-hospital death (1.4%
vs 1.1%), Q-wave myocardial infarction (MI) (0.9% vs 1.1%), and emerg
ent CABG (1.5% vs 1.0%, for women and men, respectively) were not sign
ificantly different. Nonemergent CABG was more frequent in women (1.8%
vs 0.9%; p <0.05) and length of hospital stay after device interventi
on was longer (4.4 days vs 3.8 days in men; p <0.01). In both univaria
te and multivariate analyses gender did not emerge as a significant va
riable in relation to the combined endpoint, death, Q-wave MI, or emer
gent CABG at hospital discharge. At 1-year follow-vp more women than m
en reported improvement In angina (70% vs 62%) and fewer women than me
n had had repeat revascularization (32% vs 36%). Similar proportions w
ere alive and free of angina, Q-wave MI and repeat revascularization (
46% of women vs 45% of men). Although several procedure-related compli
cations were more frequent in women than men after coronary interventi
ons with new devices, no important disadvantages were observed for wom
en in the rates of major clinical events at hospital discharge and at
1-year clinical follow-up. Additional studies are needed to evaluate t
he complex interplay of clinical, vessel, and lesion characteristics o
n success and complications of specific interventional techniques and
to determine whether gender, per se, is a risk factor and whether gend
er specific interventional strategies may be beneficial. (C) 1997 by E
xcerpta Medico, Inc.